Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation

BackgroundEmerging evidence suggests that sphingolipids may be involved in type 2 diabetes. However, the exact signaling defect through which disordered sphingolipid metabolism induces β-cell dysfunction remains unknown. The current study demonstrated that sphingosine-1-phosphate (S1P), the product...

Full description

Bibliographic Details
Main Authors: Seok-Woo Hong, Jinmi Lee, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
Format: Article
Language:English
Published: Academya Publishing Co. 2018-09-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-33-403.pdf
id doaj-985086c6c8c04ba984c71e683b689698
record_format Article
spelling doaj-985086c6c8c04ba984c71e683b6896982020-11-25T02:21:55ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782018-09-0133340341210.3803/EnM.2018.33.3.403Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial DysregulationSeok-Woo Hong0Jinmi Lee1Hyemi Kwon2Se Eun Park3Eun-Jung Rhee4Cheol-Young Park5Ki-Won Oh6Sung-Woo Park7Won-Young Lee8Institute of Medical Research, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaInstitute of Medical Research, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, .KoreaBackgroundEmerging evidence suggests that sphingolipids may be involved in type 2 diabetes. However, the exact signaling defect through which disordered sphingolipid metabolism induces β-cell dysfunction remains unknown. The current study demonstrated that sphingosine-1-phosphate (S1P), the product of sphingosine kinase (SphK), is an essential factor for maintaining β-cell function and survival via regulation of mitochondrial action, as mediated by prohibitin (PHB).MethodsWe examined β-cell function and viability, as measured by mitochondrial function, in mouse insulinoma 6 (MIN6) cells in response to manipulation of cellular S1P and PHB levels.ResultsLack of S1P induced by sphingosine kinase inhibitor (SphKi) treatment caused β-cell dysfunction and apoptosis, with repression of mitochondrial function shown by decreases in cellular adenosine triphosphate content, the oxygen consumption rate, the expression of oxidative phosphorylation complexes, the mitochondrial membrane potential, and the expression of key regulators of mitochondrial dynamics (mitochondrial dynamin-like GTPase [OPA1] and mitofusin 1 [MFN1]). Supplementation of S1P led to the recovery of mitochondrial function and greatly improved β-cell function and viability. Knockdown of SphK2 using small interfering RNA induced mitochondrial dysfunction, decreased glucose-stimulated insulin secretion (GSIS), and reduced the expression of PHB, an essential regulator of mitochondrial metabolism. PHB deficiency significantly reduced GSIS and induced mitochondrial dysfunction, and co-treatment with S1P did not reverse these trends.ConclusionAltogether, these data suggest that S1P is an essential factor in the maintenance of β-cell function and survival through its regulation of mitochondrial action and PHB expression.https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-33-403.pdfSphingosine 1-phosphateSphingosine kinaseInsulin-secreting cellsMitochondriaProhibitin
collection DOAJ
language English
format Article
sources DOAJ
author Seok-Woo Hong
Jinmi Lee
Hyemi Kwon
Se Eun Park
Eun-Jung Rhee
Cheol-Young Park
Ki-Won Oh
Sung-Woo Park
Won-Young Lee
spellingShingle Seok-Woo Hong
Jinmi Lee
Hyemi Kwon
Se Eun Park
Eun-Jung Rhee
Cheol-Young Park
Ki-Won Oh
Sung-Woo Park
Won-Young Lee
Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
Endocrinology and Metabolism
Sphingosine 1-phosphate
Sphingosine kinase
Insulin-secreting cells
Mitochondria
Prohibitin
author_facet Seok-Woo Hong
Jinmi Lee
Hyemi Kwon
Se Eun Park
Eun-Jung Rhee
Cheol-Young Park
Ki-Won Oh
Sung-Woo Park
Won-Young Lee
author_sort Seok-Woo Hong
title Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
title_short Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
title_full Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
title_fullStr Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
title_full_unstemmed Deficiency of Sphingosine-1-Phosphate Reduces the Expression of Prohibitin and Causes β-Cell Impairment via Mitochondrial Dysregulation
title_sort deficiency of sphingosine-1-phosphate reduces the expression of prohibitin and causes β-cell impairment via mitochondrial dysregulation
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2018-09-01
description BackgroundEmerging evidence suggests that sphingolipids may be involved in type 2 diabetes. However, the exact signaling defect through which disordered sphingolipid metabolism induces β-cell dysfunction remains unknown. The current study demonstrated that sphingosine-1-phosphate (S1P), the product of sphingosine kinase (SphK), is an essential factor for maintaining β-cell function and survival via regulation of mitochondrial action, as mediated by prohibitin (PHB).MethodsWe examined β-cell function and viability, as measured by mitochondrial function, in mouse insulinoma 6 (MIN6) cells in response to manipulation of cellular S1P and PHB levels.ResultsLack of S1P induced by sphingosine kinase inhibitor (SphKi) treatment caused β-cell dysfunction and apoptosis, with repression of mitochondrial function shown by decreases in cellular adenosine triphosphate content, the oxygen consumption rate, the expression of oxidative phosphorylation complexes, the mitochondrial membrane potential, and the expression of key regulators of mitochondrial dynamics (mitochondrial dynamin-like GTPase [OPA1] and mitofusin 1 [MFN1]). Supplementation of S1P led to the recovery of mitochondrial function and greatly improved β-cell function and viability. Knockdown of SphK2 using small interfering RNA induced mitochondrial dysfunction, decreased glucose-stimulated insulin secretion (GSIS), and reduced the expression of PHB, an essential regulator of mitochondrial metabolism. PHB deficiency significantly reduced GSIS and induced mitochondrial dysfunction, and co-treatment with S1P did not reverse these trends.ConclusionAltogether, these data suggest that S1P is an essential factor in the maintenance of β-cell function and survival through its regulation of mitochondrial action and PHB expression.
topic Sphingosine 1-phosphate
Sphingosine kinase
Insulin-secreting cells
Mitochondria
Prohibitin
url https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-33-403.pdf
work_keys_str_mv AT seokwoohong deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT jinmilee deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT hyemikwon deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT seeunpark deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT eunjungrhee deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT cheolyoungpark deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT kiwonoh deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT sungwoopark deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
AT wonyounglee deficiencyofsphingosine1phosphatereducestheexpressionofprohibitinandcausesbcellimpairmentviamitochondrialdysregulation
_version_ 1724864601699385344